We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Working on Guidance to Adapt Vaccines to COVID-19 Variants
FDA Working on Guidance to Adapt Vaccines to COVID-19 Variants
The FDA intends to publish draft guidance in the next several weeks outlining the data it will require for modifying authorized vaccines to address new COVID-19 viral variants, according to FDA Acting Commissioner Janet Woodcock.